BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15020569)

  • 1. Comparison of two cluster sampling methods for health surveys in developing countries.
    Milligan P; Njie A; Bennett S
    Int J Epidemiol; 2004 Jun; 33(3):469-76. PubMed ID: 15020569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination coverage in Northern Province, Papua New Guinea.
    Mirou P; Masere D
    P N G Med J; 1983 Jun; 26(2):99-101. PubMed ID: 6593968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infant immunization coverage in Italy: estimates by simultaneous EPI cluster surveys of regions. ICONA Study Group.
    Salmaso S; Rota MC; Ciofi Degli Atti ML; Tozzi AE; Kreidl P
    Bull World Health Organ; 1999; 77(10):843-51. PubMed ID: 10593033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two survey methodologies to assess vaccination coverage.
    Luman ET; Worku A; Berhane Y; Martin R; Cairns L
    Int J Epidemiol; 2007 Jun; 36(3):633-41. PubMed ID: 17420165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simplified general method for cluster-sample surveys of health in developing countries.
    Bennett S; Woods T; Liyanage WM; Smith DL
    World Health Stat Q; 1991; 44(3):98-106. PubMed ID: 1949887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cluster survey for determination of regular vaccination coverage among children.
    Shah H
    JNMA J Nepal Med Assoc; 2008; 47(170):91-3. PubMed ID: 18709039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insurance status and vaccination coverage among US preschool children.
    Santoli JM; Huet NJ; Smith PJ; Barker LE; Rodewald LE; Inkelas M; Olson LM; Halfon N
    Pediatrics; 2004 Jun; 113(6 Suppl):1959-64. PubMed ID: 15173467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the EPI survey methodology for estimating relative risk.
    Harris DR; Lemeshow S
    World Health Stat Q; 1991; 44(3):107-14. PubMed ID: 1949878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
    Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
    Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in timely vaccination coverage among children living in low-income households.
    Smith PJ; Jain N; Stevenson J; Männikkö N; Molinari NA
    Arch Pediatr Adolesc Med; 2009 May; 163(5):462-8. PubMed ID: 19414693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and simulation study of the immunization Data Quality Audit (DQA).
    Woodard S; Archer L; Zell E; Ronveaux O; Birmingham M
    Ann Epidemiol; 2007 Aug; 17(8):628-33. PubMed ID: 17553701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
    Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
    Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with underimmunization at 3 months of age in four medically underserved areas.
    Bardenheier BH; Yusuf HR; Rosenthal J; Santoli JM; Shefer AM; Rickert DL; Chu SY
    Public Health Rep; 2004; 119(5):479-85. PubMed ID: 15313111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants.
    Lin TY; Wang YH; Chang LY; Huang YC; Kao HT; Lin PY; Lu HK; Chavand P; Ortiz E
    Int J Infect Dis; 2007 Mar; 11(2):129-36. PubMed ID: 16762579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
    Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
    Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence.
    Daza P; Banda R; Misoya K; Katsulukuta A; Gessner BD; Katsande R; Mhlanga BR; Mueller JE; Nelson CB; Phiri A; Molyneux EM; Molyneux ME
    Vaccine; 2006 Sep; 24(37-39):6232-9. PubMed ID: 16806603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
    Lin TY; Wang YH; Huang YC; Chiu CH; Lin PY; Chen CJ; Chavand P; Ortiz E
    Int J Infect Dis; 2007 Nov; 11(6):488-95. PubMed ID: 17349809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.